The estimated Net Worth of Charles R Eyler is at least 541 千$ dollars as of 4 February 2019. Charles Eyler owns over 87 units of Puma Biotechnology Inc stock worth over 79,893$ and over the last 12 years Charles sold PBYI stock worth over 460,963$.
Charles has made over 10 trades of the Puma Biotechnology Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Charles sold 87 units of PBYI stock worth 2,405$ on 4 February 2019.
The largest trade Charles's ever made was selling 1,322 units of Puma Biotechnology Inc stock on 1 December 2017 worth over 139,418$. On average, Charles trades about 427 units every 37 days since 2012. As of 4 February 2019 Charles still owns at least 31,957 units of Puma Biotechnology Inc stock.
You can see the complete history of Charles Eyler stock trades at the bottom of the page.
Charles's mailing address filed with the SEC is 10880 Wilshire Blvd, Los Angeles, CA 90024, USA.
Over the last 13 years, insiders at Puma Biotechnology Inc have traded over 168,440,369$ worth of Puma Biotechnology Inc stock and bought 2,655,298 units worth 48,866,148$ . The most active insiders traders include Capital Partners Gp, L.L.C....、Steven Lo、Troy Edward Wilson. On average, Puma Biotechnology Inc executives and independent directors trade stock every 18 days with the average trade being worth of 60,225$. The most recent stock trade was executed by Michael Patrick Miller on 12 August 2024, trading 23,358 units of PBYI stock currently worth 81,519$.
we focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
Puma Biotechnology Inc executives and other stock owners filed with the SEC include: